Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luxin Yang

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive DonorsYibo Wu, Jimin Shi, Yamin Tan, et al.
Cancer Reports (Hoboken, N.J.)|July 2, 2026
Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B-ALL After CAR-T Therapy and HSCT: A Case SeriesHonghu Li, Luxin Yang, Lizhen Liu, et al.
Journal of Environmental Management|May 18, 2023
Enhanced methane production from the co-digestion of food waste and thermally hydrolyzed sludge filtrateKai Feng, Luxin Yang, Liang Chen, et al.
Bone Marrow Transplantation|October 20, 2020
Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysisLuxin Yang, Yamin Tan, Jimin Shi, et al.
BMC Cancer|March 20, 2019
Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case reportMengqi Jin, Yongxian Hu, Wenjun Wu, et al.
Materials (Basel, Switzerland)|November 13, 2025
Enhancing CO<sub>2</sub> Reduction Performance on Cu-Based Catalysts: Modulating Electronic Properties and Molecular ConfigurationsHuimin Han, Luxin Yang, Chao Han, et al.
Frontiers in Pharmacology|August 9, 2021
Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic LeukemiaYadan Liu, Bin Liang, Yan Liu, et al.
BMC Cancer|May 25, 2019
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case reportMengqi Jin, Yongxian Hu, Wenjun Wu, et al.
Annals of Hematology|June 3, 2024
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patientsMingyue Pan, Yibo Wu, Luxin Yang, et al.
Bone Marrow Transplantation|February 2, 2020
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutationsAiyun Jin, Jingjing Feng, Guoqing Wei, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive DonorsYibo Wu, Jimin Shi, Yamin Tan, et al.
Cancer Reports (Hoboken, N.J.)|July 2, 2026
Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B-ALL After CAR-T Therapy and HSCT: A Case SeriesHonghu Li, Luxin Yang, Lizhen Liu, et al.
Journal of Environmental Management|May 18, 2023
Enhanced methane production from the co-digestion of food waste and thermally hydrolyzed sludge filtrateKai Feng, Luxin Yang, Liang Chen, et al.
Bone Marrow Transplantation|October 20, 2020
Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysisLuxin Yang, Yamin Tan, Jimin Shi, et al.
BMC Cancer|March 20, 2019
Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case reportMengqi Jin, Yongxian Hu, Wenjun Wu, et al.
Materials (Basel, Switzerland)|November 13, 2025
Enhancing CO<sub>2</sub> Reduction Performance on Cu-Based Catalysts: Modulating Electronic Properties and Molecular ConfigurationsHuimin Han, Luxin Yang, Chao Han, et al.
Frontiers in Pharmacology|August 9, 2021
Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic LeukemiaYadan Liu, Bin Liang, Yan Liu, et al.
BMC Cancer|May 25, 2019
Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case reportMengqi Jin, Yongxian Hu, Wenjun Wu, et al.
Annals of Hematology|June 3, 2024
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patientsMingyue Pan, Yibo Wu, Luxin Yang, et al.
Bone Marrow Transplantation|February 2, 2020
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutationsAiyun Jin, Jingjing Feng, Guoqing Wei, et al.
Pageof 7